Cardiovascular-kidney-metabolic syndrome: A step toward multidisciplinary and inclusive care

Cell Metab. 2023 Dec 5;35(12):2104-2106. doi: 10.1016/j.cmet.2023.10.015.ABSTRACTIn a recent Presidential Advisory report, the American Heart Association (AHA) defined cardiovascular-kidney-metabolic (CKM) syndrome as a spectrum of pathology associated with dysfunctional or excess adiposity and leading to adverse cardiovascular outcomes. Implementing the guidelines set forth by the AHA has the potential to improve population-wide CKM health.PMID:38056429 | DOI:10.1016/j.cmet.2023.10.015
Source: Cell Metabolism - Category: Cytology Authors: Source Type: research